|
⚲
|
| Keyboard |
| Esposito Pamela
✚
|
|
|---|---|
| CIK # | 0001744425 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001744425] | |
| 4 | [0001744425] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kymera Therapeutics Inc | |
| Esposito Pamela | |
| Replimune Group Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-03-20 | Sell | 1,200 | $79.94 | 95,928 |
|
Kymera Therapeutics Inc KYMR
Stock Option (Right to Buy) · derivative
|
2026-03-20 | Option exercise | 2,500 | $0.00 | |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-03-20 | Option exercise | 2,500 | $49.10 | 122,750 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-03-20 | Sell | 700 | $77.71 | 54,397 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-03-20 | Sell | 600 | $79.24 | 47,544 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-02-20 | Sell | 1,900 | $87.06 | 165,414 |
|
Kymera Therapeutics Inc KYMR
Stock Option (Right to Buy) · derivative
|
2026-02-20 | Option exercise | 2,500 | $0.00 | |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-02-20 | Sell | 600 | $88.10 | 52,860 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-02-20 | Option exercise | 2,500 | $49.10 | 122,750 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-01-20 | Sell | 4,900 | $67.99 | 333,151 |
|
Kymera Therapeutics Inc KYMR
Stock Option (Right to Buy) · derivative
|
2026-01-20 | Option exercise | 3,000 | $0.00 | |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-01-20 | Sell | 200 | $68.52 | 13,704 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-01-20 | Option exercise | 3,000 | $31.20 | 93,600 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-01-20 | Option exercise | 2,500 | $49.10 | 122,750 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-01-20 | Sell | 400 | $66.68 | 26,672 |
|
Kymera Therapeutics Inc KYMR
Stock Option (Right to Buy) · derivative
|
2026-01-20 | Option exercise | 2,500 | $0.00 | |
|
Kymera Therapeutics Inc KYMR
Stock Option (Right to Buy) · derivative
|
2025-12-17 | Option exercise | 12,563 | $0.00 | |
|
Kymera Therapeutics Inc KYMR
Stock Option (Right to Buy) · derivative
|
2025-12-17 | Option exercise | 3,000 | $0.00 | |
|
Kymera Therapeutics Inc KYMR
Stock Option (Right to Buy) · derivative
|
2025-12-17 | Option exercise | 12,000 | $0.00 | |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2025-12-17 | Sell | 14,505 | $81.56 | 1,183,028 |
| showing 20 of 118 most recent transactions | |||||